论文部分内容阅读
研究鼻咽癌分期。材料与方法首次放疗前经ＣＴ扫描检查的鼻咽癌２０４例，１９７９年长沙分期法和１９９２年福州分期法进行评价。结果本组随访率为９４．６％，５年生存率为５２．２％。按’９２福州分期法本组各项分布是：Ⅰ期２．５％，Ⅱ期２２．１％，Ⅲ期４８．５％，Ⅳ期２４．０％，Ⅳｂ期２．９％：各期５年生存率分别是８０％，７６．２％，５２．７％，４３．７％和０％。结论作者建议：（１）将原发肿瘤局限在鼻咽腔者列为Ｔ１。（２）将Ⅳ期分为Ⅳ。期（Ｔ４或Ｎ３）和Ⅳｂ期（任何Ｔ，任何Ｎ，Ｍ１）。
Study of nasopharyngeal carcinoma staging. Materials and Methods 204 cases of nasopharyngeal carcinoma examined by CT scanning before radiotherapy for the first time, Changsha staging method in 1979 and Fuzhou staging method in 1992 were evaluated. Results The follow-up rate was 94.6% in this group, and the 5-year survival rate was 52.2%. According to ’92 Fuzhou staging method of this group the distribution is: Ⅰ 2.5%, Ⅱ 22.1%, Ⅲ 48.5%, Ⅳ Ⅳ 24.0%, Ⅳ b 2.9%: all stages The 5-year survival rates were 80%, 76.2%, 52.7%, 43.7% and 0%, respectively. Conclusion The authors suggest: (1) the primary tumor confined to the nasopharyngeal cavity were listed as T1. (2) Ⅳ will be divided into Ⅳ. (T4 or N3) and IVb (any T, any N, M1).